Target intelligence / Profile preview

Pathogenic bacteria in colon

Molecular classification
Other
01

Overview

"Pathogenic bacteria in the colon" refers to any of a large, diverse, and dynamic group of bacterial species capable of causing disease within the human large intestine. These bacteria are not a single entity but a category that includes Gram-negative and Gram-positive organisms such as Escherichia coli (pathogenic strains), Klebsiella pneumoniae, Bacteroides fragilis, Salmonella spp., Shigella spp., Clostridium perfringens, and others[1][2][6]. Pathogenic potential arises from specific virulence factors like toxin production, the ability to invade or damage colonic epithelium, immune evasion, or inflammation induction[2][3]. Their presence can contribute to acute infections (e.g., gastroenteritis), chronic inflammation (e.g., inflammatory bowel disease), and are implicated in colorectal carcinogenesis. There is no single molecular target or structure for all "pathogenic bacteria in colon"—it is a taxonomically and functionally diverse set defined solely by pathogenic capacity and context.\n\nKey limitations: \n- This is not a molecular target but a broad organismal category; it cannot be structurally interrogated, classified, or drugged like a receptor or enzyme.\n- For detailed, actionable drug target information, identification of a specific pathogenic bacterial species or specific virulence factor is necessary.\n\nSummary: \n- "Pathogenic bacteria in colon" is a non-canonical, unspecific designation describing a diverse group of disease-causing bacteria found in the human colon. It is not considered a drug target in the classical, molecular sense[1][2][6].

Other names
Colonic pathogenGut pathogenic bacteriumEnteric pathogen
02

Mechanism of action

Antibiotics: Inhibit bacterial cell wall synthesis, protein synthesis, DNA replication, or metabolic pathways leading to bacterial death or stasis\nProbiotics: Compete with pathogens for nutrients and attachment sites; modulate host immune responses; produce antimicrobial substances\nFecal microbiota transplantation: Restores normal microbial community to suppress pathogen expansion

03

Biological functions

InfectionColonizationImmune evasionToxin productionInflammation induction
04

Disease associations

InfectionInflammationCancer (colorectal carcinogenesis)Other (including dysbiosis-associated diseases)
05

Safety considerations

Antibiotic resistanceDisruption of commensal microbiota (dysbiosis)Risk of opportunistic infectionsPotential for promoting resistance or altering microbiome function (e.g., with broad-spectrum interventions)
06

Interacting drugs

Antibiotics (e.g., metronidazole, vancomycin, ciprofloxacin)

2 more in the full profile.

07

Biomarkers

Pathogen-specific DNA or RNA (via PCR, sequencing)Pathogen-associated toxins (e.g., C. difficile toxins)Inflammatory markers in stool (e.g., calprotectin)

Beyond the preview

Go deeper on Pathogenic bacteria in colon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria in colon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call